Grantee & Partner News | National Center for Advancing Translational Sciences

Skip to main content

U.S. Department of Health & Human Services

National Institutes of Health

In the Spotlight

MRI scans of a patient with a glioblastoma (brain tumor). Getty Images

Patients With Brain Cancer May Benefit From Treatment to Boost White Blood Cells

Washington University School of Medicine in St. Louis ∙ 01/27/2023 ∙ CTSA Program

Patients with glioblastoma, a devastating brain cancer, receive treatment that frequently leads to the unfortunate side effect of low white blood cell counts that lasts six months to a year. The low numbers of white blood cells are associated with shorter survival — but the specific reason for the prolonged drop in white blood cells and the link with shorter survival has vexed scientists.

A new study, supported in part by a CTSA Program grant and led by Washington University School of Medicine in St. Louis, reveals at least one cause of low white blood cell counts in patients treated for glioblastoma and demonstrates a potential treatment strategy that improves survival in mice.

February 2023

President Biden Announces Key Appointments to National Cancer Advisory Board
The White House ∙ 02/02/2023 ∙ NCATS
Financial Coaching for Parents in Clinic Leads to Higher Attendance at Well-Child Health Care Visits for Their Young Children
University of California, Los Angeles ∙ 02/02/2023 ∙ CTSA Program

January 2023

Congress Takes Steps Toward Reducing Animal Experimentation in 2023 Omnibus Spending Package
Physicians Committee for Responsible Medicine ∙ 01/31/2023 ∙ Tissue Chip
Non-Invasive Neurotechnology Reduces Symptoms of Insomnia and Improves Autonomic Nervous System Function
Wake Forest Baptist Medical Center ∙ 01/27/2023 ∙ CTSA Program
A Natural Non-Invasive Neuro-Technology Improves Sleep and Wellbeing in Randomized, Controlled Clinical Trial
Arizona Bioindustry Association, Inc. ∙ 01/27/2023 ∙ CTSA Program
Patients With Brain Cancer May Benefit From Treatment to Boost White Blood Cells
Washington University School of Medicine in St. Louis ∙ 01/27/2023 ∙ CTSA Program
New Discovery Leads the Way to Reverse Osteoporosis — With a Pill
Florida International University ∙ 01/23/2023 ∙ NCATS
UK Physical Therapist Explores Recovery Challenges After ICU Stay
University of Kentucky ∙ 01/20/2023 ∙ CTSA Program
For Shared Decision-Making, Telemedicine May Be as Effective as In-Person Appointments
American College of Surgeons ∙ 01/19/2023 ∙ CTSA Program
For Shared Decision-Making, Telemedicine May Be as Effective as In-Person Appointments
American College of Surgeons ∙ 01/19/2023 ∙ CTSA Program
Researchers Analyze Walking Patterns Using 3D Technology in Community Settings
UC Davis Health ∙ 01/18/2023 ∙ CTSA Program
Do Sexual Orientation and Gender Identity Affect Your Stroke Risk?
University of California, San Francisco ∙ 01/18/2023 ∙ CTSA Program
Chipping Away at the Causes of Polycystic Kidney Disease
NIH Director's Blog ∙ 01/17/2023 ∙ Tissue Chip
Mayo Clinic Researchers Link Ovarian Cancer to Bacteria Colonization in Microbiome
Mayo Clinic ∙ 01/16/2023 ∙ CTSA Program
Study Confirms No Benefit to Taking Ivermectin for COVID-19 Symptoms
Duke Clinical Research Institute ∙ 01/12/2023 ∙ CTSA Program
mRNA COVID Vaccine Technology Is Leading Breakthroughs in Addressing Very Rare Diseases
Genetic Literacy Project ∙ 01/12/2023 ∙ Rare Diseases
Discovery of Cross-Species Signaling Pathway Unlocks Mysteries Around Parasite Immunity and Development
University of Maryland College of Agriculture and Natural Resources ∙ 01/12/2023 ∙ Division of Preclinical Innovation
New Studies Suggest Social Isolation Is a Risk Factor for Dementia in Older Adults, Point to Ways to Reduce Risk
Johns Hopkins Medicine ∙ 01/12/2023 ∙ CTSA Program
Markey Study Addresses Colorectal Cancer Disparities in Black Communities
University of Kentucky ∙ 01/10/2023 ∙ CTSA Program
Santhera and ReveraGen Announce FDA Acceptance of New Drug Application for Vamorolone in Duchenne Muscular Dystrophy
Santhera Pharmaceuticals and ReveraGen BioPharma ∙ 01/09/2023 ∙ NCATS
Microphysiological Systems: A Promising New Platform for Alzheimer’s Drug Development
NIA ∙ 01/05/2023 ∙ Tissue Chip
Primary Language of Mothers Linked to Continued Breastfeeding During NICU Hospitalization
Boston University Clinical & Translational Science Institute ∙ 01/04/2023 ∙ CTSA Program
Gut Bacteria May Play a Role in Diabetes
Cedars-Sinai ∙ 01/03/2023 ∙ CTSA Program
Biomedical Innovation Program Grants Awards to Develop New Diagnostics and Medical Devices
Oregon Health & Science University ∙ 01/03/2023 ∙ CTSA Program

December 2022

Study Reveals How Chronic Blood Cancer Transitions to Aggressive Disease
Washington University School of Medicine in St. Louis ∙ 12/29/2022 ∙ CTSA Program
Study Reveals How Chronic Blood Cancer Transitions to Aggressive Disease
Washington University School of Medicine in St. Louis ∙ 12/29/2022 ∙ CTSA Program
NIH Researchers Use 3D Bioprinting to Create Eye Tissue
NEI ∙ 12/22/2022 ∙ 3-D Modeling, Division of Preclinical Innovation
CHOP and NJIT Researchers Develop New Tool for Studying Multiple Characteristics of a Single Cell
Children’s Hospital of Philadelphia ∙ 12/21/2022 ∙ CTSA Program
Cash Incentives Can Help Boost Weight-Loss Programs in Individuals Living in Low-Income Neighborhoods
NIH Office of Behavioral and Social Sciences Research ∙ 12/20/2022 ∙ CTSA Program
Study Confirms No Benefit to Taking Ivermectin for COVID-19 Symptoms
Duke University Health System ∙ 12/16/2022 ∙ CTSA Program
Research Brief: Medical Terminology Can Be Confusing for Patients
University of Minnesota Medical School ∙ 12/15/2022 ∙ CTSA Program
UC Davis Alpha Stem Cell Clinic Receives $8 Million From California’s Stem Cell Agency
UC Davis Health ∙ 12/14/2022 ∙ CTSA Program
Third Pole Therapeutics Receives $32M Strategic Equity Investment to Accelerate Its Tankless Inhaled Nitric Oxide (iNO) Platform
Third Pole Therapeutics, Inc. ∙ 12/14/2022 ∙ NCATS
Building Equity in Biomedical Research
Harvard Medical School ∙ 12/14/2022 ∙ CTSA Program
ISS National Lab Highlights Scientific Research Milestones in 2022
ISS National Laboratory ∙ 12/14/2022 ∙ Tissue Chip
Rural Hospital Closures Affect Operations of Surrounding Hospitals
Penn State College of Medicine ∙ 12/13/2022 ∙ CTSA Program
Combo of Bad Cholesterol and High Blood Pressure May Increase Heart Attack or Stroke Risk
American Heart Association, Inc. ∙ 12/13/2022 ∙ NCATS
Virginia Tech Scientist Uncovers Possible Neural Link Between Early Life Trauma and Binge-Eating Disorder
Virginia Polytechnic Institute and State University ∙ 12/12/2022 ∙ CTSA Program
Do Former Football Players Age Faster?
Harvard Medical School ∙ 12/08/2022 ∙ CTSA Program
Sharing What We Have Learned: Healthy City Collaborative
University of Illinois at Chicago ∙ 12/07/2022 ∙ CTSA Program
Study Supports Urging Smoking-Cessation Treatment to Patients in Cancer Care
Washington University in St. Louis ∙ 12/06/2022 ∙ CTSA Program
OHSU Partners with Semiconductor Company to Develop Smartwatch That Detects Depression in Teens
Oregon Health & Science University ∙ 12/06/2022 ∙ CTSA Program
Collaborative Drug Discovery Announces New NIH Grant to Develop Cloud Workspaces for Drug Discovery
Collaborative Drug Discovery, Inc. ∙ 12/05/2022 ∙ NCATS
State iTHRIV Partnership Awards $200,000 in Pilot Funds
Virginia Polytechnic Institute and State University ∙ 12/05/2022 ∙ CTSA Program
Reducing Youth Interest in Flavored Vaping Products
University of Minnesota ∙ 12/05/2022 ∙ CTSA Program
Peanuts and Herbs and Spices May Positively Impact Gut Microbiome
Penn State ∙ 12/02/2022 ∙ CTSA Program
Peanuts and Herbs and Spices May Positively Impact Gut Microbiome
Penn State ∙ 12/01/2022 ∙ CTSA Program

November 2022

Is Optimism the Secret to a Long Life?
Boston University ∙ 11/30/2022 ∙ CTSA Program
Simulated Driving Program Reduces Crash Risk for Teens with ADHD in Small Study
NICHD ∙ 11/30/2022 ∙ CTSA Program
Study Uses COVID Outbreak Modeling Tool to Predict Opioid Overdose Death Trends
University of Florida, Institute of Food and Agricultural Sciences ∙ 11/28/2022 ∙ CTSA Program
Scientist Academy Introduces High School Students to Health and Science Research
UC Davis Health ∙ 11/23/2022 ∙ CTSA Program
The Critical Importance of Lowering LDL-C in High-Risk Patients
North American Thrombosis Forum ∙ 11/22/2022 ∙ CTSA Program
Atomic Changes Reshaping our Data Journey in Small Steps
BioTeam ∙ 11/22/2022 ∙ NCATS
Immune Cells Control Waste Clearance in the Brain
NIH Research Matters ∙ 11/22/2022 ∙ CTSA Program
A Growing Trend of Antibody Evasion by New Omicron Subvariants
The Ohio State University ∙ 11/22/2022 ∙ CTSA Program
Nanotechnology May Better Identify, Treat Ectopic Pregnancy
Oregon Health & Science University ∙ 11/21/2022 ∙ CTSA Program
Collaborative Drug Discovery Announces New NIH Grant to Develop Virtual Approaches to New Chemistries
Collaborative Drug Discovery, Inc. ∙ 11/21/2022 ∙ ASPIRE
Collaborative Drug Discovery Announces New NIH Grant to Develop Intelligent Chemical Structure Browser
Collaborative Drug Discovery, Inc. ∙ 11/21/2022 ∙ NCATS
CMS Data Now Available in N3C
University of Kentucky ∙ 11/18/2022 ∙ CTSA Program
Space Mission to Investigate Drug Treatment for Age-Related Muscle Loss
University of Florida College of Pharmacy ∙ 11/17/2022 ∙ Tissue Chip
University Of Alabama at Birmingham: Clinical Trial for Rare Genetic Disease Gets Assistance from Artificial Intelligence
India Education Diary ∙ 11/17/2022 ∙ Biomedical Data Translator
Research Brief: Association Between Diabetes Medication and Less Severe Cases of COVID-19
University of Minnesota Medical School ∙ 11/17/2022 ∙ CTSA Program
‘Nudges,’ Complexity, and Private Information Factor into Informed Consent’s Evolution
The Association of Clinical Research Professionals ∙ 11/16/2022 ∙ NCATS
Lung Infections Caused by Soil Fungi Are a Problem Nationwide
Washington University School of Medicine in St. Louis ∙ 11/16/2022 ∙ CTSA Program
Remote Data Collection: The Solution to WEIRD Sample Groups
Emotiv ∙ 11/11/2022 ∙ NCATS
Residence Habits for Continual Again Ache Relief Disc of Arizona
johnathanskmsh.ezblogz.com ∙ 11/11/2022 ∙ NCATS
NCATS Translational Science Interagency Fellowship Program 2023
Empowerment Opportunities ∙ 11/11/2022 ∙ NCATS
7 Exercises for Lower Back Ache Reduction Dr Nael Shanti
massagesinauroraco85050.ezblogz.com ∙ 11/10/2022 ∙ NCATS
Researchers Develop Miniature Human Organ Model That Mimics Pregnancy
The University of Texas Medical Branch at Galveston ∙ 11/09/2022 ∙ Tissue Chip
NIH Funds UAMS Study Addressing Urgent Health Needs of Pregnant Marshallese Women
University of Arkansas for Medical Sciences ∙ 11/09/2022 ∙ CTSA Program
NCATS’ Rutter: Bringing Mmore Treatments to All People More Quickly’
BioCentury, Inc. ∙ 11/09/2022 ∙ NCATS
Study Finds Half of Patients with Low-Grade Proteinuria Develop Treatable Lupus Nephritis Within Two Years
American College of Rheumatology ∙ 11/08/2022 ∙ NCATS
After Showing Early Potential, Cholesterol Medication Fenofibrate Fails to Cut Severe Symptoms or Death in COVID-19 Patients
Penn Medicine ∙ 11/07/2022 ∙ New Therapeutic Uses
Crowded Emergency Departments May Affect Patients Throughout the Hospital
Penn State ∙ 11/04/2022 ∙ CTSA Program
Clinical Trial for Rare Genetic Disease Gets Assistance from Artificial Intelligence
The University of Alabama at Birmingham ∙ 11/04/2022 ∙ Rare Diseases
Study Examines Immunotherapy’s Effect on COVID-19 Outcomes
University of Cincinnati ∙ 11/03/2022 ∙ CTSA Program
Study Finds That Patients with Cancer and a Suppressed Immune System Are at High Risk for Severe COVID if Treated with Systemic Drug Therapies
Dana-Farber Cancer Institute ∙ 11/03/2022 ∙ CTSA Program
Reduced-Nicotine Cigarettes Result in Less Smoking in Anxious, Depressed Smokers
Penn State ∙ 11/02/2022 ∙ CTSA Program
Blue Clarity, LLC Announces Crowdsourcing Challenge to Minimize Bias in Healthcare
Yahoo! Finance ∙ 11/01/2022 ∙ NCATS
Skin Compounds Associated with Attractiveness to Mosquitoes
NIH Research Matters ∙ 11/01/2022 ∙ CTSA Program
Study: First-Degree Relatives of Patients with NAFLD at Risk of Liver Disease
UC San Diego Health ∙ 11/01/2022 ∙ CTSA Program

October 2022

Perceived Discrimination Increased the Risk of Worse Health Outcomes After a Heart Attack
Amer ∙ 10/31/2022 ∙ NCATS
Non-English Speakers are Rarely Included in Pediatrics Research, Study Finds
UPMC ∙ 10/31/2022 ∙ CTSA Program
Perceived Discrimination Increased the Risk of Worse Health Outcomes After a Heart Attack
American Heart Association, Inc. ∙ 10/31/2022 ∙ NCATS
Which Children Are at Risk After a Mild Traumatic Brain Injury?
Children's Hospital Los Angeles ∙ 10/31/2022 ∙ NCATS
Media Advisory: No Increase in Risk of Serious Pregnancy Complications During Early Pandemic, NIH-Funded Study Suggests
NICHD ∙ 10/28/2022 ∙ NCATS
Discovery of Endocannabinoid Gene Mutation Leads to Identification of New, Rare Pediatric Neurological Disease
Rady Children’s Institute for Genomic Medicine ∙ 10/27/2022 ∙ CTSA Program
Santhera and ReveraGen Complete NDA Submission to FDA for Vamorolone in Duchenne Muscular Dystrophy
Santhera Pharmaceuticals and ReveraGen BioPharma ∙ 10/27/2022 ∙ NCATS
New Strategy Shows Potential to Block Nerve Loss in Neurodegenerative Diseases
Washington University School of Medicine in St. Louis ∙ 10/26/2022 ∙ CTSA Program
From Bench to Business to Bedside: Translating Research to Medicine at CWRU
Case Western Reserve University ∙ 10/25/2022 ∙ SBIR/STIR
Telehealth Follow-Up Associated with Increased Returns and Hospitalizations After Emergency Department Visit
University of California, Los Angeles ∙ 10/25/2022 ∙ CTSA Program
NKF/TOS Urge Collaboration, Clinical Strategies to Improve Understanding of Managing Co-Existing Relationship Between Obesity, Chronic Kidney Disease
The Obesity Society ∙ 10/21/2022 ∙ NCATS
Study Finds No Benefit to Taking Fluvoxamine for COVID-19 Symptoms
Duke University Health System ∙ 10/19/2022 ∙ CTSA Program
Researchers Developing New Model for Treating, Managing Chronic Pain Without Opioids
University of Massachusetts Lowell ∙ 10/19/2022 ∙ Tissue Chip
Icahn School of Medicine at Mount Sinai Receives National Institutes of Health Award to Accelerate Development of New Treatments
Icahn School of Medicine at Mount Sinai ∙ 10/17/2022 ∙ CTSA Program
When ‘Nudging’ Goes Too Far: $1.6M to Support Research into Ethics of Recruiting Research Participants
Case Western Reserve University ∙ 10/17/2022 ∙ NCATS
Crew-4 Astronauts Return to Earth After Working on ISS National Lab Research
ISS National Laboratory ∙ 10/17/2022 ∙ Tissue Chip
Miniature Models Made to Aid Drug Development
NIH Record ∙ 10/14/2022 ∙ 3-D Modeling, Tissue Chip
NIH Funds UAMS Effort to Close Patient Outcome Gaps Across U.S. Level 1 and 2 Trauma Centers
University of Arkansas for Medical Sciences ∙ 10/13/2022 ∙ CTSA Program
Research Brief: Medical Jargon Is Source of Confusion for Non-Physicians
University of Minnesota Medical School ∙ 10/13/2022 ∙ CTSA Program
What is Kratom? - National Institute of Health Overview of Kratom
Dailygram ∙ 10/13/2022 ∙ HEAL
Is Alcoholism Hereditary?
Canadian Centre for Addiction ∙ 10/12/2022 ∙ GARD
Study Identifies Meditation as Potential Strategy for Reducing Healthcare Worker Burnout
Duke University School of Medicine ∙ 10/11/2022 ∙ CTSA Program
UF to Lead Community-Engaged Research Network for the All of Us Research Program
University of Florida Health ∙ 10/10/2022 ∙ CTSA Program
FDA and NCATS Offering Grants to Develop Tissue Chips for Botulinum Toxin Testing
ALTEX - Alternatives to Animal Experimentation ∙ 10/10/2022 ∙ SBIR/STIR
Georgia Clinical and Translational Science Alliance Receives $73.7 Million to Accelerate Research Across Georgia
Emory University ∙ 10/06/2022 ∙ CTSA Program
Georgia Clinical & Translational Science Alliance Receives $73.7 Million to Accelerate Clinical and Translational Research Across Georgia
Georgia Institute of Technology ∙ 10/06/2022 ∙ CTSA Program
Wyss Researchers Discover a New Type of RNA That Inhibits a Broad Range of Viral Infections
Wyss Institute ∙ 10/05/2022 ∙ Tissue Chip
Smoking Increases the Risk of Illness and Viral Infection, Including Type of Coronavirus
UC Davis Health ∙ 10/05/2022 ∙ CTSA Program
Santhera Submits Marketing Authorization Application to the European Medicines Agency for Vamorolone in Duchenne Muscular Dystrophy
Santhera Pharmaceuticals ∙ 10/03/2022 ∙ NCATS
Fewer Asian, Black, Hispanic Patients Eligible for Drugs That May Delay Alzheimer’s Progression
University of California, San Francisco ∙ 10/03/2022 ∙ CTSA Program
Santhera Submits Marketing Authorization Application to the European Medicines Agency for Vamorolone in Duchenne Muscular Dystrophy
Santhera Pharmaceuticals ∙ 10/03/2022 ∙ NCATS
Innovation to Respond to COVID-19
U.S. Food and Drug Administration ∙ 10/01/2022 ∙ Division of Preclinical Innovation

September 2022

UAB Study on Chorioamnionitis Directly Harming the Brains of Preterm Infants Receives NIH Funding for Further Exploration
The University of Alabama at Birmingham ∙ 09/30/2022 ∙ CTSA Program
Northwestern, CERN Join NIH in Enhancing Access to Biomedical Research
Northwestern University, Feinberg School of Medicine ∙ 09/28/2022 ∙ CTSA Program
How Long Older Adults Will Live Comes Down to 17 Often Surprising Factors
Duke University Health System ∙ 09/28/2022 ∙ CTSA Program
Life Expectancy Tool May Improve Quality of Life for Patients with Dementia
University of California, San Francisco ∙ 09/26/2022 ∙ CTSA Program
UAMS Researchers Find Changes in Monkeypox Genome That May Explain Its Recent Rapid Spread
University of Arkansas for Medical Sciences ∙ 09/26/2022 ∙ CTSA Program
Study: Often Overlooked, Molecules Called Glycans Regulate COVID-19 Spike Protein Function
University at Buffalo ∙ 09/26/2022 ∙ CTSA Program
Detecting the Earliest Population Changes of COVID-19 Activity with Wearable Devices
The Scripps Research Institute ∙ 09/23/2022 ∙ CTSA Program
A Consistent Lack of Sleep Negatively Impacts Immune Stem Cells
GhScientific ∙ 09/23/2022 ∙ CTSA Program
Landmark Study of Biomarker Data May Enable Better Treatment for Early Onset Dementia
University of California, San Francisco ∙ 09/22/2022 ∙ NCATS
Accurate Assessment of Heart Rhythm Can Optimize Chemotherapy Use
UNC Lineberger Comprehensive Cancer Center ∙ 09/22/2022 ∙ CTSA Program
University of Kansas Medical Center Announces Nearly $27 Million NIH Grant to Accelerate Clinical and Translational Research in the Region
University of Kansas Medical Center ∙ 09/21/2022 ∙ CTSA Program
A Consistent Lack of Sleep Negatively Impacts Immune Stem Cells, Increasing Risk of Inflammatory Disorders and Heart Disease
Icahn School of Medicine at Mount Sinai ∙ 09/21/2022 ∙ NCATS
Spirituality, Religion Linked to Heart Health Among Black Americans
NIH Research Matters ∙ 09/20/2022 ∙ CTSA Program
Can Children Swab Themselves for COVID-19? New Study Suggests Yes
Georgia Institute of Technology ∙ 09/20/2022 ∙ CTSA Program
UAMS Part of $6 Million National Effort to Make Testing for Toxins in Water and People Less Costly, Easier
University of Arkansas for Medical Sciences ∙ 09/20/2022 ∙ CTSA Program
UAMS Researcher Receives Prestigious National Award, $1 Million to Support Falls Research in Older Adults
University of Arkansas for Medical Sciences ∙ 09/19/2022 ∙ CTSA Program
Monthly Caps on Out-of-Pocket Costs Could Provide Financial Relief to Privately Insured Patients
Boston University School of Public Health ∙ 09/16/2022 ∙ NCATS
Office of New Drugs Regulatory Science Research
U.S. Food and Drug Administration, Center for Drug Evaluation and Research ∙ 09/13/2022 ∙ NCATS
Biomedical Advance Targets a Major Contributor to Cardiovascular Disease
Florida International University, College of Engineering & Computing ∙ 09/12/2022 ∙ Division of Preclinical Innovation
New Study Describes How Best Practices Can Be Applied to Community Engagement Programs
Boston University School of Medicine ∙ 09/12/2022 ∙ CTSA Program
Study Describes How Best Practices Can be Applied to Community Engagement Programs
Boston University School of Medicine ∙ 09/12/2022 ∙ CTSA Program
$61M Grant Funds Translational Science at Weill Cornell Medicine
Weill Cornell Medicine ∙ 09/09/2022 ∙ CTSA Program
Researchers Identify a Potential Path Against Inherited Neurological Disease
Icahn School of Medicine at Mount Sinai ∙ 09/08/2022 ∙ NCATS
Cedars-Sinai Study Highlights Cancer Disparities in LA County
Cedars Sinai ∙ 09/05/2022 ∙ CTSA Program
Tackling Inflammatory Bowel Disease with Tumbling Microrobots
Purdue University ∙ 09/05/2022 ∙ NCATS
Answering the Challenges of Rare Disease Market Access with HEOR
AmerisourceBergen Corporation ∙ 09/01/2022 ∙ GARD
Using Improv to Address COVID Vaccine Hesitancy
University of Rochester Medical Center ∙ 09/01/2022 ∙ CTSA Program

August 2022

Leading Translational Gastroenterology Research
Northwestern University, Feinberg School of Medicine ∙ 08/30/2022 ∙ Rare Diseases
Children’s Sleep Linked to Brain Development
NIH Research Matters ∙ 08/30/2022 ∙ CTSA Program
Full-Dose Anticoagulation Treatment Prevented Blood Clots in COVID-19 Patients
Brigham and Women's Hospital ∙ 08/29/2022 ∙ CTSA Program
NIH-Funded Pediatric COVID-19 Testing Study Finds School-Aged Children Can Self-Swab
NIBIB ∙ 08/26/2022 ∙ CTSA Program
National Institutes of Health Renews Mayo Clinic’s $48 Million Clinical and Translational Science Award
Mayo Clinic ∙ 08/25/2022 ∙ CTSA Program
Religious Practices, Spirituality Associated with Higher Levels of Heart Health Among African Americans
Mayo Clinic ∙ 08/24/2022 ∙ CTSA Program
How New Motion-Sensing Technology May Help Standardize Back-Pain Care
The Ohio State University ∙ 08/23/2022 ∙ CTSA Program
Opiant Pharmaceuticals Announces Notice of Allowance for U.S. Patent with Claims Covering OPNT004 for the Treatment of Cannabinoid Hyperemesis Syndrome
Opiant ∙ 08/22/2022 ∙ NCATS
Diabetes Drug Metformin Shows Potential Benefit in Large COVID-19 Trial
Northwestern University ∙ 08/19/2022 ∙ CTSA Program
Neuron Membrane Lipid May Contribute to Alzheimer’s Development, Progression
Penn State College of Medicine ∙ 08/18/2022 ∙ CTSA Program
COVID OUT Clinical Trial Suggests Metformin Effective at Reducing Odds of Serious Outcomes for COVID-19 Patients Seeking Early Treatment
University of Minnesota Medical School ∙ 08/17/2022 ∙ CTSA Program
New Explorer’s Career Plan? Advocate for Those Fighting Rare Diseases
La Salle University ∙ 08/16/2022 ∙ GARD
Gene Mutations from Patients with Debilitating Seizure and Movement Disorder Created in Mice
University of Maryland School of Medicine ∙ 08/15/2022 ∙ CTSA Program
E-Cigarette Use to Reduce Cigarette Smoking May Not Increase Nicotine Dependence
Penn State ∙ 08/15/2022 ∙ CTSA Program
Scripps Research Scientists Identify How SARS-CoV-2 Spreads in the Middle East
The Scripps Research Institute ∙ 08/15/2022 ∙ CTSA Program
The Last of the “Unplucked” Gems: Targeting Nav1.7 for Chronic Pain
International Association for the Study of Pain Research Forum ∙ 08/12/2022 ∙ NCATS
CTSC Releases New Team Science Strategy Modules
Case Western Reserve University ∙ 08/12/2022 ∙ CTSA Program
Markey Study: Betamethasone Could Improve Outcomes for Prostate Cancer Radiation Therapy
University of Kentucky ∙ 08/12/2022 ∙ CTSA Program
Social Determinants of Health Are Important Contributors to Mortality Disparities in U.S., Study Finds
Johns Hopkins Medicine ∙ 08/11/2022 ∙ CTSA Program
UAMS Researcher Co-Authors Nature Communications Article Showing Higher Heart Failure Rates in Some COVID-19 Patients
University of Arkansas for Medical Sciences ∙ 08/11/2022 ∙ CTSA Program
Monoclonal Antibody Reduces Asthma Attacks in Urban Youth
NIAID ∙ 08/10/2022 ∙ CTSA Program
Study Shows PPE Was Highly Effective Against COVID-19 in Emergency Department Workers
The University of Alabama at Birmingham ∙ 08/08/2022 ∙ CTSA Program
Genetic Variant for Alzheimer's Disease May Increase Risk of Chronic Traumatic Encephalopathy After Repetitive Head Impact
Neurology Today (American Academy of Neurology) ∙ 08/04/2022 ∙ CTSA Program
The Digital Phenotype of Vaccination
Nat Biotechnol ∙ 08/04/2022 ∙ CTSA Program
Dance with Me? Study Uses Music to Soothe Dementia Patients and Caregivers
Penn State ∙ 08/02/2022 ∙ CTSA Program

July 2022

Coming Wave of Opioid Overdoses 'Will Be Worse than Ever Been Before'
Northwestern University ∙ 07/28/2022 ∙ CTSA Program
Research Brief: Researchers Determine That AI-Based Tools Have Not Yet Reached Full Diagnostic Potential in COVID-19
University of Minnesota Medical School ∙ 07/28/2022 ∙ CTSA Program
Hearing Loss and Tinnitus Are Common In Cancer Survivors
University of California, San Francisco ∙ 07/27/2022 ∙ CTSA Program
Study Supports Potential of Genome-to-Treatment (GTRx™) to Guide Physicians in the Management of 500 Treatable Genetic Diseases
Rady Children’s Institute for Genomic Medicine ∙ 07/26/2022 ∙ Division of Preclinical Innovation, GARD
Tracking SARS-CoV-2 Variants in Wastewater
NIH Research Matters ∙ 07/26/2022 ∙ CTSA Program
‘Smart Necklace’ Biosensor May Track Health Status Through Sweat
The Ohio State University ∙ 07/22/2022 ∙ CTSA Program
Cultivating an Effective Research Team Through Application of Team Science Principles
Society of Clinical Research Associates ∙ 07/21/2022 ∙ CTSA Program
Do Benefits of Physical, Mental Activity on Thinking Differ for Men and Women?
American Academy of Neurology ∙ 07/20/2022 ∙ NCATS
ACTIV-6 Trials Show No Benefit to Fluticasone Furoate for COVID-19 Symptoms
Duke Clinical Research Institute ∙ 07/19/2022 ∙ CTSA Program
Mobile App for Improving Heart Health Among African Americans Shows Promise, Mayo Study Finds
Mayo Clinic ∙ 07/18/2022 ∙ CTSA Program
Mobile App for Improving Heart Health Among African Americans Shows Promise, Mayo Study Finds
Mayo Clinic ∙ 07/18/2022 ∙ CTSA Program
Immune Modulator Drugs Improved Survival for People Hospitalized with COVID-19
University of North Carolina, Gillings School of Global Public Health ∙ 07/15/2022 ∙ CTSA Program
Funding, Freedom, Flexibility: Graduate Research Fellowship Helps Students Pursue Passions
Arizona State University ∙ 07/15/2022 ∙ 3-D Modeling
Is a National Healthcare Database in our Future?
Smith Hanley Associates, LLC ∙ 07/14/2022 ∙ CTSA Program
UCLA CTSI Receives $59-Million Clinical and Translational Science Award
UCLA Clinical and Translational Science Institute ∙ 07/14/2022 ∙ CTSA Program
NUCATS Town Hall Offers Overview of Resources, 2023 Renewal Efforts
Northwestern University Clinical and Translational Sciences Institute ∙ 07/14/2022 ∙ CTSA Program
Long Day Wear Experience with Water Surface Daily Disposable Contact Lenses
The Ohio State University, College of Optometry ∙ 07/14/2022 ∙ CTSA Program
Study Finds No Benefit to Taking Fluticasone Furoate for COVID-19 Symptoms
Duke University Health System ∙ 07/13/2022 ∙ CTSA Program
Preterm Birth More Likely with Exposure to Phthalates
NIEHS ∙ 07/11/2022 ∙ CTSA Program
NIH-Funded Tissue Chip Investigations to Fly on SpaceX CRS-25 Mission to the ISS
ISS National Laboratory ∙ 07/08/2022 ∙ Tissue Chip
Scientists Develop Tools for Early Detection of SARS-CoV-2 Variants in Wastewater
The Scripps Research Institute ∙ 07/07/2022 ∙ CTSA Program
A Major Step Forward for Organ Biofabrication
Harvard John A. Paulson School of Engineering and Applied Sciences ∙ 07/07/2022 ∙ Tissue Chip
The Biomedical Data Translator Consortium Provides Progress Updates in Latest Companion Publications
RENCI ∙ 07/07/2022 ∙ Biomedical Data Translator
Eight Junior Faculty Begin Mentored Career Development KL2 Program
Penn State ∙ 07/07/2022 ∙ CTSA Program
Taking on a Rare Childhood Disease and Triple-Negative Breast Cancer
Oregon Health & Science University ∙ 07/07/2022 ∙ CTSA Program
Convalescent Plasma Doesn’t Help Severely Ill COVID Patients: Study
Vanderbilt University Medical Center ∙ 07/07/2022 ∙ CTSA Program
International Space Station National Lab Sponsoring Diverse Set of Experiments Launching on SpaceX CRS-25
ISS National Laboratory ∙ 07/06/2022 ∙ Tissue Chip
Study Shows Convalescent Plasma Doesn’t Benefit Severely Ill Patients Hospitalized with COVID-19
Vanderbilt University Medical Center ∙ 07/05/2022 ∙ CTSA Program

June 2022

UCLA Receives Clinical and Translational Science Award from the National Center for Advancing Translational Sciences
University of California, Los Angeles ∙ 06/29/2022 ∙ CTSA Program
Yogic Breathing Affects Cerebrospinal Fluid Dynamics During Breathing Practice
NCCIH ∙ 06/28/2022 ∙ CTSA Program
Grant Money Available to Reduce Health Disparities
University of Virginia ∙ 06/27/2022 ∙ CTSA Program
Light During Sleep in Older Adults Linked to Obesity, Diabetes, High Blood Pressure
Northwestern University ∙ 06/27/2022 ∙ CTSA Program
Genetic Variant May Increase Risk for CTE Severity Among Older Individuals with Repetitive Head Impacts
Boston University School of Medicine ∙ 06/27/2022 ∙ CTSA Program
New Genetic Associations in Pediatric NAFLD Affect Both Risk and Severity
University of California, San Diego ∙ 06/27/2022 ∙ CTSA Program
Local Stroke Center May Be Off Limits to Patients in Black Neighborhoods
University of California, San Francisco ∙ 06/27/2022 ∙ CTSA Program
Changing the Trajectory to Accelerate Rare Disease Drug Development
Certara ∙ 06/24/2022 ∙ Rare Diseases
New Concept Poised to Accelerate Drug Discovery Through Data Mining
RENCI (Renaissance Computing Institute) ∙ 06/24/2022 ∙ Biomedical Data Translator
Modeling a Devastating Childhood Disease on a Chip
Wyss Institute ∙ 06/23/2022 ∙ Tissue Chip
Five-Year, Multi-Site Trial to Assess Lymphedema Prevention Concludes
Vanderbilt University Medical Center ∙ 06/20/2022 ∙ CTSA Program
Walking Gives the Brain a ‘Step-Up’ in Function for Some
University of Rochester Medical Center ∙ 06/17/2022 ∙ CTSA Program
Computer Tool Can Track Stroke Rehabilitation to Boost Recovery
NYU Langone Health ∙ 06/16/2022 ∙ CTSA Program
Treating Parkinson’s Disease with Pinpoint Precision
I Am Intramural Blog ∙ 06/15/2022 ∙ Division of Preclinical Innovation
Study Finds No Benefit to Taking Ivermectin for COVID-19 Symptoms
Duke University Health System ∙ 06/13/2022 ∙ CTSA Program
Pediatric Liver Disease Increases Risk of Developing Type 2 Diabetes
University of California, San Diego ∙ 06/13/2022 ∙ CTSA Program
Santhera and ReveraGen to Present New Data with Vamorolone at 2022 Parent Project Muscular Dystrophy Conference
Santhera Pharmaceuticals ∙ 06/09/2022 ∙ NCATS
Study Reveals Genetic Differences Among Fetal Monocytes
Northwestern University, Feinberg School of Medicine ∙ 06/09/2022 ∙ CTSA Program
How Might Chimeric, Droplet-Forming Proteins Contribute to Cancer?
University at Buffalo ∙ 06/08/2022 ∙ IDG
Using AI to Advance Understanding of Long COVID Syndrome
NIH Director's Blog ∙ 06/07/2022 ∙ CTSA Program
UAMS, CAVHS Studying Health Effects of Arkansas Veterans’ Exposure to Burn Pits in Middle East
University of Arkansas for Medical Sciences ∙ 06/07/2022 ∙ CTSA Program
Causes of Liver Cancer are Changing Around the World: Some Up, Some Down
University of California, San Diego ∙ 06/06/2022 ∙ CTSA Program
NIH-Supported Study Links Poor Sleep to Increased Risk of COPD Flare-ups
NHLBI ∙ 06/06/2022 ∙ CTSA Program
‘You Need a Village’: Clinical Trial Leaders Discuss Collaborations, COVID, and Widening the Lens
The University of Chicago, Polsky Center for Entrepreneurship and Innovation ∙ 06/05/2022 ∙ NCATS
Leveraging Turncoat Immune Cells to Combat Cancer
I Am Intramural Blog ∙ 06/03/2022 ∙ Division of Preclinical Innovation
xCures joins C-Path’s Cure Drug Repurposing Collaboratory to Deliver AI-enabled Data Abstraction of Health Records
xCures ∙ 06/02/2022 ∙ NCATS
Exercise Amplifies Immune Attack on Pancreatic Cancer
NYU Langone Health ∙ 06/02/2022 ∙ CTSA Program
RENCI and RTI International Expand Strategic Partnership
RENCI (Renaissance Computing Institute) ∙ 06/02/2022 ∙ Biomedical Data Translator
Exploiting a Vulnerability in an Aggressive Leukemia Affecting Babies
Boston Children's Hospital ∙ 06/01/2022 ∙ CTSA Program
Consortium Spotlight: Advancing Discoveries in Mitochondrial Diseases
Rare Diseases Clinical Research Network ∙ 06/01/2022 ∙ RDCRN
Gene Therapy for Rare Eye Disease Safe but Lacks Efficacy in Early Trial
NIH ∙ 06/01/2022 ∙ GARD

May 2022

UK Study: Asymptomatic COVID-19 Could Still Cause Pregnancy Risks
University of Kentucky ∙ 05/31/2022 ∙ CTSA Program
UK Study: Asymptomatic COVID-19 Could Still Cause Pregnancy Risks
University of Kentucky ∙ 05/30/2022 ∙ CTSA Program
Inappropriate Antibiotics for Nonhospitalized Kids Cost US At Least $74 Million
Washington University in St. Louis ∙ 05/26/2022 ∙ CTSA Program
Inappropriate Antibiotics for Nonhospitalized Kids Cost US at Least $74 Million
Washington University in St. Louis ∙ 05/26/2022 ∙ CTSA Program
Georgia State Researchers Awarded More Than $6 Million to Fight Emerging Diseases with Midwest Antiviral Drug Discovery Center
Georgia State University ∙ 05/26/2022 ∙ NCATS
Patient Spotlight: Estopinan Family Advocates for TK2-Related Mitochondrial DNA Depletion Syndrome
Rare Diseases Clinical Research Network ∙ 05/26/2022 ∙ RDCRN
Use Cases Show Translator's Potential to Expedite Clinical Research
North Carolina Translational and Clinical Sciences Institute ∙ 05/23/2022 ∙ Biomedical Data Translator
U of M Receives NIAID Grant to Develop Drug Treatments for Future Viral Pandemics
University of Minnesota Medical School ∙ 05/23/2022 ∙ Division of Preclinical Innovation
First Treatment for Eosinophilic Esophagitis Wins FDA Approval
Cincinnati Children's Hospital Medical Center ∙ 05/20/2022 ∙ RDCRN
Deadly Disparities in the Time of COVID-19: Behind the Report
University of Illinois Chicago, Center for Clinical and Translational Science ∙ 05/19/2022 ∙ CTSA Program
Early Stage Investigator Spotlight: Zarazuela Zolkipli-Cunningham Designs Novel Outcome Measures for Mitochondrial Disease
Rare Diseases Clinical Research Network ∙ 05/19/2022 ∙ RDCRN
COVID Booster Needed for Broad Protection against Omicron Variants
The Ohio State University ∙ 05/18/2022 ∙ CTSA Program
A Computational Approach to Curbing Chemotherapy’s Side Effects
I Am Intramural Blog ∙ 05/17/2022 ∙ Division of Preclinical Innovation
Innovation through Academic-Industry Partnerships in Clinical Trials
The University of Chicago, Polsky Center for Entrepreneurship and Innovation ∙ 05/16/2022 ∙ NCATS
Scientists Use Machine Learning Models to Help Identify Long COVID Patients
University of North Carolina School of Medicine ∙ 05/16/2022 ∙ CTSA Program
U.S. Patent Awarded to FIU Researchers Could Be Key to Treating and Preventing Cardiovascular Disease
Florida International University, College of Engineering & Computing ∙ 05/16/2022 ∙ Division of Preclinical Innovation
Healing Chronic Pain? An Update on the NIH’s $2 Billion HEAL Project to End Chronic Pain
Health Rising ∙ 05/15/2022 ∙ HEAL
In New Age of Telemedicine, CHOP Researchers Identify Child Neurology Patients Who Still Require In-Person Visits
The Children’s Hospital of Philadelphia ∙ 05/13/2022 ∙ CTSA Program
Markey Study Finds 'Super Gene' Shows Promise for Preventing Obesity
University of Kentucky ∙ 05/13/2022 ∙ CTSA Program
Sound Pharmaceuticals Receives NIH Grant for Covid-19 Therapy Development
Pharmaceutical Technology ∙ 05/12/2022 ∙ NCATS
Five Questions with Qi Sun
Harvard Catalyst ∙ 05/12/2022 ∙ CTSA Program
Clinical and Translational Research Receives $61 Million Grant Support
Washington University in St. Louis ∙ 05/12/2022 ∙ CTSA Program
Sound Pharmaceuticals’ NIH Grant for a Novel Oral COVID-19 Treatment Increases to $4.2M
Sound Pharmaceuticals, Inc. ∙ 05/11/2022 ∙ NCATS
Smell and Taste Loss Less Likely with Newer COVID-19 Variants
Virginia Commonwealth University ∙ 05/11/2022 ∙ CTSA Program
U.S. Patent Awarded to FIU Researchers Could Be Key to Treating and Preventing Cardiovascular Disease
Florida International University ∙ 05/11/2022 ∙ Division of Preclinical Innovation
Netflix’s ‘Bandersnatch’ Inspires UAMS Researchers’ Opioid Misuse Game for Adolescents
University of Arkansas for Medical Sciences ∙ 05/11/2022 ∙ CTSA Program
Smoking-Cessation Program That Targets Cancer Patients Effective
Washington University School of Medicine in St. Louis ∙ 05/11/2022 ∙ CTSA Program
FSU Continues to Advance Translational Research with New Grant from the National Library of Medicine
Florida State University ∙ 05/11/2022 ∙ CTSA Program
Medication That Lowers Risk of Overdose Underused
Washington University School of Medicine in St. Louis ∙ 05/10/2022 ∙ CTSA Program
DoD Vision, Focused Translational Team Science Award
Global Database Ltd. ∙ 05/10/2022 ∙ Division of Preclinical Innovation
The Essentials of Single IRB Review
Harv ∙ 05/06/2022 ∙ CTSA Program
NCATS-Funded WUSTL Research Uses Synthetic Data to Accurately Model COVID-19 Populations
Federal Laboratory Consortium for Technology Transfer ∙ 05/05/2022 ∙ CTSA Program
Antibiotics Less Effective in Kids with More Appendicitis Pain
FitnessBblogger ∙ 05/05/2022 ∙ CTSA Program
SC CTSI and Georgia CTSA Partner Creating Innovative Career Training and Advancement Platform
Southern California Clinical and Translational Science Institute ∙ 05/05/2022 ∙ CTSA Program
Use Cases Show Translator’s Potential to Expedite Clinical Research
RENCI (Renaissance Computing Institute) ∙ 05/04/2022 ∙ Biomedical Data Translator
BioSystics, Inc. Is Introducing the BioSystics Analytics Platform™️ (BioSystics-AP™️) at the Microphysiology Systems World Summit in New Orleans, May 30–June 3, 2022
BioSystics, Inc. ∙ 05/04/2022 ∙ Tissue Chip
Vitamins, Minerals Improve Symptoms for Children with ADHD
Oregon Health & Science University ∙ 05/04/2022 ∙ CTSA Program
International Study Finds Nearly 13% of COVID-19 Hospitalized Patients Had Serious Neurologic Symptoms
Boston University School of Medicine ∙ 05/04/2022 ∙ CTSA Program
Blood Marker Shows Potential for Tracking Frontotemporal Dementia
NIH Research Matters ∙ 05/03/2022 ∙ Rare Diseases
Youths of Color Use Photographs to Highlight Health-care Inequities throughout COVID-19 Pandemic
Boston University School of Medicine ∙ 05/02/2022 ∙ CTSA Program
NJ ACTS Pilot Program Letter of Intent Deadline May 6, 2022
Rutgers Institute for Translational Medicine and Science ∙ 05/02/2022 ∙ CTSA Program

April 2022

Ridner Concludes Five-Year Multisite Trial to Assess Lymphedema Prevention
Vanderbilt University ∙ 04/28/2022 ∙ CTSA Program
Science Update: Youth Suicides Increased in First Year of the Pandemic, NIH-Funded Study Suggests
NICHD ∙ 04/27/2022 ∙ CTSA Program
Three CTSA Program Hubs Announced as Recipients of the 2022 AAMC Innovations Award
University of Rochester Center for Leading Innovation and Collaboration (CLIC) ∙ 04/27/2022 ∙ CTSA Program
Synthetic Data Mimics Real Patient Data, Accurately Models COVID-19 Pandemic
Washington University School of Medicine in St. Louis ∙ 04/27/2022 ∙ CTSA Program
Making Movement Fun May Help New Moms with Heart Risks
NHLBI ∙ 04/26/2022 ∙ CTSA Program
Viruses in the Gut Influence Inflammatory Bowel Disease
NIH Research Matters ∙ 04/26/2022 ∙ CTSA Program
Presumptive Service Connection for Rare Respiratory Cancers Due to Exposure to Fine Particulate Matter
Federal Register ∙ 04/26/2022 ∙ Rare Diseases
A More Precise Way to Knock Out Skin Rashes
NIH Director's Blog ∙ 04/26/2022 ∙ NCATS
2022 ICTS Symposium Posters
Washington University in St. Louis, Institute of Clinical and Translational Sciences ∙ 04/25/2022 ∙ CTSA Program
If You Build It, Will They Come? Linking ICTS Researcher Engagement and Scientific Productivity
Washington University in St. Louis, Institute of Clinical and Translational Sciences ∙ 04/25/2022 ∙ CTSA Program
Federal Research Funding Has Positive ‘Ripple Effects’
The Ohio State University ∙ 04/22/2022 ∙ NCATS
Early Stage Investigator Spotlight: Siddharth Srivastava Investigates Genetic Causes of Neurodevelopmental Disorders
Rare Diseases Clinical Research Network ∙ 04/21/2022 ∙ RDCRN
Introducing SARS-CoV-2 Variants Overview, NLM’s Latest Tool in the Fight against COVID-19
National Center for Biotechnology Information ∙ 04/20/2022 ∙ Division of Preclinical Innovation
Hesperos Shows Potential for In Vitro Approach to Replace Conventional Animal Efficacy Studies for Rare Neuromuscular Disorders
Hesperos, Inc. ∙ 04/19/2022 ∙ SBIR/STIR, Tissue Chip
Smartwatches and Fitness Bands Reveal Individual Physiological Responses to COVID-19 Vaccine
The Scripps Research Institute ∙ 04/19/2022 ∙ CTSA Program
Isotonizene Can Be Fun for Anyone
mybjjblog.com ∙ 04/15/2022 ∙ NCATS
NCATS Aims to Transform Rare Disease Research
NIH Record ∙ 04/15/2022 ∙ Rare Diseases
Consortium Spotlight: Advancing Discoveries in Neurodevelopmental Disorders
Rare Diseases Clinical Research Network ∙ 04/14/2022 ∙ RDCRN
New COVID-19 Nasal Spray Outperforms Current Antibody Treatments in Mice
Northwestern University ∙ 04/13/2022 ∙ Tissue Chip
Science Update: Scientists Develop Noninvasive Method to Predict Congenital CMV Infection
NICHD ∙ 04/13/2022 ∙ CTSA Program
Three Doses of COVID-19 Vaccine Important for Patients Who Undergo Solid Organ Transplants
Washington University in St. Louis ∙ 04/13/2022 ∙ CTSA Program
The National Economic Burden of Rare Disease Study
EveryLife Foundation for Rare Diseases ∙ 04/12/2022 ∙ Rare Diseases
Five Questions With Lotfi Merabet
Harvard Catalyst ∙ 04/12/2022 ∙ CTSA Program
CHOP Division of Urology Research Highlights 2021-2022
Children’s Hospital of Philadelphia ∙ 04/12/2022 ∙ CTSA Program
Research in Human Kidney Organoids Reveals Target to Prevent Irreversible Kidney Damage
MassaMassachusetts General Hospital ∙ 04/11/2022 ∙ CTSA Program
BARDA Announces Winners of EHR-Focused Pediatric COVID-19 Data Challenge
Federal Laboratory Consortium for Technology Transfer ∙ 04/07/2022 ∙ NCATS
Researchers Identify Oral Bacteria Strains Linked to High Blood Pressure
NHLBI ∙ 04/06/2022 ∙ CTSA Program
A New ‘Moneyball’: Model Switches Up How Baseball Players Are Valued
ScienceBlog.com ∙ 04/06/2022 ∙ CTSA Program
Unlocking Insights from Real-World Data to Help Pediatric COVID-19 Patients
MedicalCountermeasures.gov ∙ 04/06/2022 ∙ CTSA Program
Major Grant Renewal to Provide Five More Years of Support for VICTR
Vanderbilt University Medical Center ∙ 04/06/2022 ∙ CTSA Program
FSU Team Wins Global Competition to Develop Next-Gen Tools, Improve Public Health Solutions
Florida State University ∙ 04/05/2022 ∙ NCATS
New Metric More Accurately Evaluates Physician Performance
Northwestern University ∙ 04/05/2022 ∙ CTSA Program
New Study Shows Low D3Cr Muscle Mass/Weight Significantly Increases Risk of Hip and Potentially Other Fractures in Older Men
Sutter Health ∙ 04/04/2022 ∙ CTSA Program
Convalescent Plasma Could Lower Hospitalization Risk for Newly Infected COVID-19 Patients
The University of Utah ∙ 04/04/2022 ∙ NCATS
ILLInet RECOVER Will Help to Solve the Medical Mystery of “Long COVID”
UIC Center for Clinical and Translational Science ∙ 04/02/2022 ∙ CTSA Program

March 2022

Virpax Pharmaceuticals Reports 2021 Year-End Results
Virpax® Pharmaceuticals, Inc. ∙ 03/31/2022 ∙ NCATS
Patient Spotlight: Billy Anton Balances Management and Lifestyle with Primary Ciliary Dyskinesia
Rare Diseases Clinical Research Network ∙ 03/29/2022 ∙ RDCRN
Santhera and ReveraGen Start Rolling NDA Submission to the FDA for Vamorolone for the Treatment of Duchenne Muscular Dystrophy
Yahoo! Finance ∙ 03/29/2022 ∙ NCATS
Rural Hospital Administrators’ Beliefs on Offering Obstetric Care
University of Minnesota ∙ 03/25/2022 ∙ CTSA Program
'Father of Environmental Justice' and Local High School Students Headline CCTS Conference
University of Kentucky ∙ 03/25/2022 ∙ CTSA Program
COVID-19 Infection Linked to Higher Risk of Neuropathy
Washington University School of Medicine in St. Louis ∙ 03/24/2022 ∙ CTSA Program
Biomedical Data Translator Platform Moves to the Next Phase
RENCI (Renaissance Computing Institute) ∙ 03/24/2022 ∙ Biomedical Data Translator
In Animal Study, Implant Churns Out CAR-T Cells to Combat Cancer
North Carolina State University ∙ 03/24/2022 ∙ CTSA Program
Mayo Clinic Researchers Develop New Antibody Test to Diagnose MS
Mayo Clinic ∙ 03/24/2022 ∙ CTSA Program
Early Stage Investigator Spotlight: BreAnna Kinghorn Improves Outcomes for Children with Primary Ciliary Dyskinesia
Rare Diseases Clinical Research Network ∙ 03/22/2022 ∙ RDCRN
Targeting TGF-β for Treatment of Osteogenesis Imperfecta
Baylor College of Medicine ∙ 03/22/2022 ∙ RDCRN
COVID-19 Makes Living with a Rare Disease Even Harder
National Library of Medicine ∙ 03/22/2022 ∙ RDCRN
"Fine-Tuning" Innovations to Predict Manic Episodes in Bipolar Disorder
UIC Center for Clinical and Translational Science ∙ 03/21/2022 ∙ CTSA Program
Help Us Enhance Diversity in Alzheimer’s and Related Dementias Clinical Trials
National Institute on Aging ∙ 03/21/2022 ∙ CTSA Program
Tufts CTSI Publishes First-of-Its-Kind Resource on Real-World Research Conducted with Broadly Engaged, Diverse, and Inclusive Teams
Tufts Clinical and Translational Science Institute ∙ 03/21/2022 ∙ CTSA Program
Blood Test May Indicate Higher Risk Pregnancies in Patients with COVID-19
Northwestern University ∙ 03/17/2022 ∙ CTSA Program
Relapsing Polychondritis Patients, Advocates, and Researchers Emphasize Awareness, Partnership, and Collaboration with Exhibits on Rare Disease Day 2022 at the National Institutes of Health
Relapsing Polychondritis Foundation ∙ 03/17/2022 ∙ Rare Diseases
Coaching Transforms Researchers and Institutions
University of Minnesota, Clinical & Translational Science Institute ∙ 03/16/2022 ∙ CTSA Program
Santhera and ReveraGen to Present Efficacy and Safety Data with Vamorolone at 2022 Muscular Dystrophy Association Conference
Santhera Pharmaceuticals and ReveraGen BioPharma ∙ 03/15/2022 ∙ NCATS
Finding the ‘Tipping Point’ to Permanent Kidney Damage
NIH Director's Blog ∙ 03/15/2022 ∙ Tissue Chip
Hospitalizations for High Blood Pressure May Be on the Rise
NHLBI ∙ 03/14/2022 ∙ CTSA Program
Weight Loss Doesn’t Help Pregnancy Chances, UVA’s Collaborative Health Study Finds
University of Virginia ∙ 03/14/2022 ∙ CTSA Program
Seminar Explores Similarities between Long COVID and Traumatic Brain Injury
University at Buffalo, Clinical and Translational Science Institute ∙ 03/14/2022 ∙ CTSA Program
Close the Blinds during Sleep to Protect Your Health
Northwestern University ∙ 03/14/2022 ∙ CTSA Program
Consortium Spotlight: Advancing Discoveries in Mucociliary Clearance Diseases
Rare Diseases Clinical Research Network ∙ 03/11/2022 ∙ RDCRN
Prenatal Mindfulness Program Improves Stress Response in Infants
University of California, San Francisco ∙ 03/10/2022 ∙ CTSA Program
Universal Masking in Schools is Shown to Reduce Spread of COVID-19
Duke Clinical Research Institute ∙ 03/09/2022 ∙ CTSA Program
O-pH, a New UW Dental Tool Prototype, Can Spot the Acidic Conditions That Lead to Cavities
University of Washington ∙ 03/08/2022 ∙ NCATS
COVID-19 Immune Response Improves for Months after Vaccination
NIH Research Matters ∙ 03/08/2022 ∙ CTSA Program
Getting Sufficient Sleep Reduces Calorie Intake
NIH Research Matters ∙ 03/08/2022 ∙ CTSA Program
Continuing Face Mask Use Could Save U.S. Billions of Dollars
CUNY Graduate School of Public Health and Health Policy ∙ 03/08/2022 ∙ CTSA Program
Study Shows Structural Racism Can Result in Poorer Leukemia Outcomes
University of Illinois at Chicago ∙ 03/07/2022 ∙ CTSA Program